Pasar al contenido principal

BASES ESTRUCTURALES DE LA REGULACION MEDIADA POR DOMINIOS CBS EN LA ACTIVIDAD DE LA ENZIMA CISTATIONINA BETA-SINTETASA Y DEL TRANSPORTADOR DE MAGNESIO CNNM1

PID2022-141748OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage

  • González-Recio, Irene
  • Goikoetxea-Usandizaga, Naroa
  • Rejano-Gordillo, Claudia María
  • Conter, Carolina
  • Rodriguez-Agudo, Rubén
  • Serrano-Maciá, Marina
  • Zapata-Pavas, L. Estefanía
  • Close Peña-Sanfélix, Patricia
  • Azkargorta, Mikel
  • Elortza, Félix
  • Herranz, José Maria
  • Guillamon-Thiery, Álex
  • Guerra-Ruiz, Armando Raúl
  • Jover-Atienza, Ramiro
  • Galicia-García, Unai
  • Martín, César A.
  • Schaeper, Ute
  • Cardoso-Delgado, Teresa
  • Díaz-Moreno, Irene
  • Díaz-Quintana, Antonio
  • Buccella, Daniela
  • Nogueiras, Rubén A.
  • Argemi, Josepmaria
  • Ávila, Matías A.
  • Gratacós-Ginès, Jordi
  • Pose, Elisa
  • Bataller, Ramon A.
  • Crespo-García, Javier V.
  • Martínez-Cruz, Luís Alfonso
  • Martínez-Chantar, María Luz
Chemicals and CAS Registry Numbers alcohol dehydrogenase 9031-72-5 methyltransferase 9033-25-4 alcohol 64-17-5 magnesium 7439-95-4 Ethanol Magnesium, ALD, alcohol-associated liver disease; CNNM4, Cyclin M4; ER, endoplasmic reticulum; PCMT1, L-isoaspartate O-methyltransferase; SAMe, S-adenosylmethionine; WT, wild type Supplemental Digital Content is available, Background and Aims: Alcohol-associated liver disease (ALD) is a leading cause of liver-related mortality worldwide, with limited treatment options beyond abstinence and liver transplantation. Chronic alcohol consumption has been linked to magnesium (Mg2+) deficiency, which can influence liver disease progression. The mechanisms underlying Mg2+ homeostasis dysregulation in ALD remain elusive. This study aimed to investigate the role of the Mg2+ transporter Cyclin M4 (CNNM4) in ALD by analyzing its expression patterns in patients with ALD and preclinical animal models. Approach and Results: In this study, CNNM4 is upregulated in the liver of both patients with ALD and animal models. CNNM4 overexpression triggers Mg2+ homeostasis dysregulation, linked to ALD progression. We propose a novel therapeutic approach for ALD treatment using N-acetylgalactosamine silencing RNA technology to specifically modulate Cnnm4 expression in the liver, improving mitochondrial function and alleviating endoplasmic reticulum stress. Notably, silencing Cnnm4 restores protein isoaspartyl methyltransferase (PCMT1) activity, essential for repairing ethanol-induced protein damage. Enhancing mitochondrial activity through Cnnm4-dependent mechanisms increases S-adenosylmethionine levels, crucial for PCMT1 function, highlighting the interconnected roles of mitochondrial health and protein homeostasis in ALD treatment. Conclusions: These findings shed light on the dysregulation of Mg2+ homeostasis in ALD, providing a promising therapeutic approach targeting CNNM4. N-acetylgalactosamine siCnnm4 therapy boosts the repair processes of ethanol-damaged proteins through the upregulation of PCMT1 activity., The authors acknowledge Begoña Rodríguez Iruretagoyena for the technical support., This work was supported by grants from Ministerio de Ciencia, Innovación y Universidades MICINN: PID2023-146933OB-100 funded by MCIU /AEI /10.13039/501100011033 / FEDER, UE as part of Plan Estatal de Investigación Científica y Técnica e Innovación (to MLM-C); Grant CEX2021-001136-S funded by MCIN/AEI /10.13039/501100011033 (to MLM-C); Instituto de Salud Carlos III (ISCIII) through the project PMP22/00054 "Exploring the Feasibility of predictive and pharmacodynamics biomarkers of immunotherapy in solid tumors (Immune4ALL)" and co-founded by the European Union; CIBEREHD\Project funded by CIBEREHD; La Caixa Banking Foundation under the project code CI23-20155 (CaixaImpulse) (to MLM-C); La Caixa Banking Foundation and FCT (HR17-00601) (to MLM-C); Programa Ayudas a proyectos de investigación y desarrollo en salud del Departamento de Salud del Gobierno Vasco (2023333041) (to MLM-C); Diputación Foral de Bizkaia dentro del Programa Transferencia Tecnológica 2022 (6/12/TT/2022/00001), co-founded by FEDER (to MLM-C); Proyecto Elkartek, Subvencionado por el Gobierno Vasco (to MLM-C); PhD fellowship from MINECO (REF BES-2017-080435) (to Irene González-Recio); Spanish Ministerio de Ciencia e Innovación (MICINN), Grants No PID2019-109055RB-I00, BFU2016-77408-R and PID2022-141748OB-I00, to L.A.M.-C; and grants by ERANet E-Rare No EJPRD19-040, and by Instituto Carlos III, No G95229142 (to Luis Alfonso Martínez-Cruz); PI22/01853 from reactive to perspective medicine in NAFLD: Identification a novel signature for progression in early NAFLD, PMP21/00112 Dianas terapéuticas y biomarcadores para la medicina de precision en MAFLD (PreMed-MAFLD), PI18/01304 Immunomediatd Nonalcoholic SteaTohepatItis; prevalence and CharacTerization. INSTInCT study (to Javier Crespo and Paula Iruzubieta). Instituto de Salud Carlos III FIS PI22/00910 (to Elisa Pose). Río Hortega grant (to Jordi Gratacós-Ginès), ISCIII-Acción Estratégica en Salud (AES), 2021 Call; FEDER/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación PID2021-126096NB-I00 and RED2018-102379-T; Xunta de Galicia 2021-CP085 and 2020-PG0157 (to Rubén Nogueiras); Ministerio de Ciencia, Innovación PID2021-126663NB-I00, European Regional Development Fund (FEDER), Andalusian Government (BIO-198 and P18-FR-3487, US/JUNTA/FEDER, UE), University of Seville (VI PPIT-US), and the Ramón Areces´ Foundation (to Irene Díaz-Moreno); Ministry of Science and Innovation, grant number PID2022-138572OB-C42 (to Cesar Martín); “Ayuda RYC2020-029316-I financiada por MCIN/AEI/10.13039/501100011033 y por EL FSE invierte en tu future” (to Teresa C. Delgado); Instituto Carlos III PI20/00690 (to Ramiro Jover), cofounded by the European Union., Peer reviewed